Crow Point Partners’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-6,941
| Closed | -$230K | – | 125 |
|
|
2019
Q1 | $230K | Buy |
+6,941
| New | +$230K | 0.04% | 102 |
|
|
2018
Q4 | – | Sell |
-6,098
| Closed | -$281K | – | 143 |
|
|
2018
Q3 | $281K | Buy |
6,098
+467
| +8% | +$21.5K | 0.05% | 112 |
|
|
2018
Q2 | $209K | Buy |
5,631
+4,610
| +452% | +$171K | 0.04% | 108 |
|
|
2018
Q1 | $30K | Buy |
+1,021
| New | +$30K | 0.01% | 226 |
|